Selection of treatment according to evidence-based medicine relies primarily on randomized controlled trials and meta-analyses. However, this evidence applies to the “average” patient and ignores the fact that customary clinical taxonomy does not include patterns of symptoms, severity of illness, effects of comorbid conditions, timing of phenomena, rate of progression of illness, responses to previous treatments, and other clinical distinctions that demarcate major prognostic and therapeutic differences among patients who otherwise seem to be deceptively similar since they share the same diagnosis [1].
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide? / Cosci, Fiammetta; Fava, Giovanni A.. - In: BIOMEDICINE HUB. - ISSN 2296-6870. - ELETTRONICO. - (2021), pp. 118-121. [10.1159/000519656]
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
Cosci, Fiammetta
;
2021
Abstract
Selection of treatment according to evidence-based medicine relies primarily on randomized controlled trials and meta-analyses. However, this evidence applies to the “average” patient and ignores the fact that customary clinical taxonomy does not include patterns of symptoms, severity of illness, effects of comorbid conditions, timing of phenomena, rate of progression of illness, responses to previous treatments, and other clinical distinctions that demarcate major prognostic and therapeutic differences among patients who otherwise seem to be deceptively similar since they share the same diagnosis [1].File | Dimensione | Formato | |
---|---|---|---|
Cosci & Fava_2021_BMH.pdf
Accesso chiuso
Descrizione: paper
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
136.2 kB
Formato
Adobe PDF
|
136.2 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.